Click here to view this message in a browser window.

Welcome
Welcome to the debut issue of MedConnect! MedImpact is pleased to provide you this quarterly newsletter filled with valuable insights and intelligence on pharmacy benefit management and healthcare... read more

Learn More
Survey Question
Five years into passage of the Affordable Care Act (ACA), what is your general opinion of the ACA?
After responding, if you need to make a change, click here.

MedMatters

MedImpact News

Learn about the hottest news from MedImpact, from announcements to publications to event updates... read more

MedMatters Icon

Self-funded

Changing Landscape

In the early part of the decade beginning 2010, employers that self-insured their employee drug benefit were experiencing a relatively calm period. Generic drug prices were flat to declining, lots of brand name blockbuster drugs were ending their patent period... read more

Specialty Rx Icon

Specialty Rx

Biosimilars Update

There has been some attention paid to biosimilars in the past, but now with the FDA's approval of Zarxio as the first biosimilar in the U.S., they are making headlines again. Zarxio is the biosimilar submitted for the brand name Neupogen, which is used to raise white blood... read more

MCO Commercial Icon

MCO Commercial

Hepatitis C

Hepatitis C is an infectious disease affecting primarily the liver, caused by the hepatitis C virus (HCV). The virus was discovered in 1989 and is the most common blood-borne disease in the U.S., with an estimated 3.2 million Americans infected. Sixty to 70%... read more

SUNRx Logo

340B

Active Year Ahead

More than two decades ago, Congress enacted the 340B program to enable safety net healthcare organizations to purchase pharmaceuticals at significant discounts and use this benefit to continue their mission of serving more patients and to stretch scarce resources as... read more

Drug Info

What to Watch for

In 2014, the FDA Center for Drug Evaluation and Research (CDER) approved an astounding 41 new drugs. The impact of the new Hepatitis C agents, such as Sovaldi and Harvoni, on healthcare spend in 2014 is undeniable. So what can we expect in 2015?... read more

Connect Icon

Contact Us

We Want Your Input

If you have questions about an article or suggestions for future articles, please contact us... read more

Events Icon

Upcoming Events

Visit With Us

MedImpact regularly participates in conferences, tradeshows and other industry events. Learn where we’ll be speaking, attending and exhibiting throughout the year... read more

Government Icon

Government

Medicaid Data

The Affordable Care Act (ACA) codified as Public Law 111-148 impacts the delivery of Medicaid healthcare benefits and broadens the scope of eligibility to the Medicaid program. These two aspects of ACA have been well publicized, analyzed, and have a... read more

Connect with usTwitter Facebook LinkedIn YouTube

MedImpact Logo

Copyright © 2015 MedImpact, Inc. All Rights Reserved.
10181 Scripps Gateway Court, San Diego, CA 92131

If you do not wish to receive future email, click here.